J Korean Soc Transplant.
2007 Jun;21(1):140-142.
Effect of High Dose Intravenous Immunoglobulins on the Treatment of Antibody Mediated Humoral Rejection and BK Virus Infection in Renal Transplant Recipients
- Affiliations
-
- 1Department of Internal Medicine, Soonchunhyang University School of Medicine, Seoul, Korea. jeonjs@hosp.sch.ac.kr
- 2Department of Surgery, Soonchunhyang University School of Medicine, Seoul, Korea.
Abstract
- Despite the recent advances in immunosuppression, antibody mediated acute rejection is associated with a poor prognosis. Therapeutic interventions such as polyclonal antibodies, rituximab, and plasmapheresis have been used for the treatment of antibody mediated rejection. However, these treatments are associated with a serious infectious complication. Recently, Intravenous immunoglobulin (IVIG) are known to have powerful immunomodulatory effects on inflammatory and infectious disease. We successfully rescued two patients who had concomitant antibody mediated rejection and BK virus infection. IVIG could be a preferable choice for treatment of humoral rejection in the presence of infection.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Intravenous Immunoglobulin Treatment in a Kidney Transplant Patient with Chronic Antibody-Mediated Rejection
- Current Issues in the Treatment of Chronic Antibody-Mediated Rejection in Kidney Transplantation
- CMV Disease
- Herpes Simplex Virus and Varicella Zoster Virus Infections in Adult Kidney Transplant Recipients: Incidence and Risk Factor Analysis
- Treatment of Presumptive BK Nephropathy with Ciprofloxain in Kidney Transplant Recipients: Three Case Reports
